XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.2
DERIVATIVE FINANCIAL INSTRUMENTS
 6 Months Ended
Jun. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE FINANCIAL INSTRUMENTS DERIVATIVE FINANCIAL INSTRUMENTS
The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company may enter into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. Derivative financial instruments may be used as risk management tools by the Company to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s borrowings and are not used for trading or speculative purposes.
The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. The Company, however, discontinues cash flow hedge accounting if it is probable the forecasted hedged transactions will not occur in the initially identified time period due to circumstances, such as the impact
of the COVID-19 pandemic. Upon discontinuance, the associated gains and losses deferred in AOCI are reclassified immediately into earnings and subsequent changes in the fair value of the cash flow hedge are recognized in earnings. At June 30, 2022 and December 31, 2021, the Company had no interest rate derivative designated as a hedging instrument.
The Company enters into interest rate swaps that allow its commercial loan customers to effectively convert a variable-rate commercial loan agreement to a fixed-rate commercial loan agreement. Under these agreements, the Company enters into a variable-rate loan agreement with a customer in addition to an interest rate swap agreement, which serves to effectively swap the customer’s variable-rate loan into a fixed-rate loan. The Company then enters into a corresponding swap agreement with a third party in order to economically hedge its exposure through the customer agreement. The interest rate swaps with both the customers and third parties are not designated as hedges and are marked through earnings. At June 30, 2022, the Company had 17 customer and 17 corresponding third-party broker interest rate derivatives not designated as a hedging instrument with an aggregate notional amount of $183.5 million. The Company had $75.8 million in notional amount of such derivative instruments at December 31, 2021. The Company entered into three new interest rate swaps with its commercial loan customers and recognized swap fee income of $785 thousand during the three months ended June 30, 2022 compared to one new interest rate swap that resulted in swap fee income of $15 thousand during the three months ended June 30, 2021. During the six months ended June 30, 2022 and 2021, the Company recognized swap fee income of $1.7 million from five new interest rate swaps and $68 thousand from two new interest rate swaps, respectively, which are included in noninterest income in the unaudited condensed consolidated statements of income. At June 30, 2022 and December 31, 2021, the Company provided cash collateral of $2.7 million and $260 thousand to the third parties for these derivatives, respectively. At June 30, 2022 and December 31, 2021, the Company was holding cash collateral of $6.1 million and $490 thousand from the third parties for these derivatives, respectively.
The Company also may enter into risk participation agreements with a financial institution counterparty for an interest rate derivative contract related to a loan in which the Company may be a participant or the agent bank. The risk participation agreement provides credit protection to the agent bank should the borrower fail to perform on its interest rate derivative contracts with the agent bank. The Company manages its credit risk on the risk participation agreement by monitoring the creditworthiness of the borrower, which follows the same credit review process as the derivative instruments entered into directly with the borrower. The notional amount of such risk participation agreement reflects the Company’s pro-rata share of the derivative instrument, consistent with its share of the related participated loan. At June 30, 2022 and December 31, 2021, the Company had a risk participation with sold protection with a notional value of $15.9 million for both periods, and a risk participation with purchased protection with a notional value of $5.0 million and zero at June 30, 2022 and December 31, 2021, respectively. For the three and six months ended June 30, 2021, the Company received an upfront fee of zero and $53 thousand, respectively, upon entry into the risk participation agreement with sold protection, which is included in noninterest income in the unaudited condensed consolidated statements of income. There was no upfront fee on the new risk participation during the three and six months ended June 30, 2022.
As a part of its normal residential mortgage operations, the Company will enter into an interest rate lock commitment with a potential borrower. The Company will enter into a corresponding commitment with an investor to sell that loan at a specific price shortly after origination. In accordance with FASB ASC 820, adjustments are recorded through earnings to account for the net change in fair value of these transactions for the held for sale pipeline.
The following table summarizes the fair value of the Company's derivative instruments at June 30, 2022 and December 31, 2021:
June 30, 2022December 31, 2021
Notional AmountBalance Sheet LocationFair ValueNotional AmountBalance Sheet LocationFair Value
Derivatives not designated as hedging instruments:
Interest rate swaps$91,731 Other assets$5,853 $37,915 Other assets$764 
Interest rate swaps91,731 Other liabilities(5,717)37,915 Other liabilities(758)
Risk participation - sold credit protection15,855 Other liabilities— 15,855 Other liabilities(2)
Risk participation - purchased credit protection4,992 Other assets28 — Not applicable— 
Interest rate lock commitments with customers7,713 Other assets186 16,604 Other assets353 
Forward sale commitments8,328 Other assets683 8,665 Other assets52 
Total derivatives not designated as hedging instruments$1,033 $409 
The following tables summarize the effect of the Company's derivative financial instruments on OCI and net income for the three and six months ended June 30, 2022 and 2021:
Amount of Loss Recognized in OCI on DerivativeAmount of Gain Recognized in OCI on Derivative
Three Months Ended June 30,Six Months Ended June 30,
2022202120222021
Derivatives in cash flow hedging relationships:
Interest rate products$— $(83)$— $656 
Total$— $(83)$— $656 

Amount of Loss Reclassified from AOCI into IncomeAmount of Loss Reclassified from AOCI into IncomeLocation of Loss Recognized from AOCI into Income
Three Months Ended June 30,Six Months Ended June 30,
2022202120222021
Derivatives in cash flow hedging relationships:
Interest rate products$— $(89)$— $(176)
Interest expense
Total$— $(89)$— $(176)

During the three months ended September 30, 2021, the Company terminated its interest rate swap designated as a hedging instrument of $50.0 million.
Amount of Gain (Loss) Recognized in IncomeAmount of Gain (Loss) Recognized in IncomeLocation of Gain (Loss) Recognized in Income
Three Months Ended June 30,Six Months Ended June 30,
2022202120222021
Derivatives not designated as hedging instruments:
Interest rate products$93 $(16)$130 $37 Other operating expenses
Risk participation agreement28 — 30 (4)Other operating expenses
Interest rate lock commitments with customers(113)(216)(167)(217)Mortgage banking activities
Forward sale commitment330 (171)631 83 Mortgage banking activities
Total$339 $(403)$624 $(101)